-
Blood and Lymphatic Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Blood and Lymphatic Cancer: Targets and Therapy
(25,490) Views
1179-9889
ISSN: 1179-9889
An international, peer-reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- American Chemical Society's 'Chemical Abstracts Service'
- OAIster: The Open Access initiative
- ResearchGate scientific network
Article Processing Statistics:
9 From submission of manuscript to first editorial decision (including peer-review)
-
Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in Blood and Lymphatic Cancer: Targets and Therapy
